Morgan Cheatham is a Vice President with Bessemer Venture Partners where he leads healthcare and life sciences investments from seed to growth stages. He focuses across the value chain spanning software, therapeutics, services, and diagnostics, to improve patient care from bench to bedside and specializes in applications of computation in biomedicine. Select investments in his portfolio include Abridge, Hinge Health, Headspace Health (fka Ginger), Subtle Medical, Turquoise Health, Productboard, Plenful, Groups Recover Together, Ansible Health, and FOLX Health, where he serves on the board and previousl...read more